Nexalin Technology, Inc.
Develops non-invasive neurostimulation devices for mental and neurological health.
NXL | US
Overview
Corporate Details
- ISIN(s):
- US65345B2016
- LEI:
- Country:
- United States of America
- Address:
- 1776 YORKTOWN, 77056 HOUSTON
- Website:
- https://nexalin.com
- Sector:
- Manufacturing
Description
Nexalin Technology, Inc. is a medical technology company that develops non-invasive neurostimulation devices for mental and neurological health conditions. Its core technology utilizes a patented, frequency-based waveform designed to interact with deep brain structures to modulate neurochemicals, offering a drug-free treatment alternative. The company's devices are FDA-cleared for the treatment of anxiety, insomnia, and depression. Nexalin is advancing its technology through clinical trials for expanded applications, including treatment-resistant depression, Alzheimer's disease, and substance use disorders. It is also developing next-generation systems, such as the Gen-2 and HALO devices, with a focus on enhanced therapeutic benefits and potential at-home use.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Nexalin Technology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nexalin Technology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nexalin Technology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
